Zivo Bioscience, Inc. announced it has received an updated dossier from an independent scientific review panel reconfirming the Company's Generally Recognized As Safe (GRAS) designation for its proprietary algal biomass to be marketed and used as an ingredient in a defined range of foods and beverages for human consumption. GRAS is a designation created by the U.S. Food and Drug Administration (FDA) under the Federal Food, Drug and Cosmetic Act that determines if a food ingredient or additive has adequate evidence of safety to be consumed under the conditions of intended use. GRAS status conveys to manufacturers and marketers that they are able to safely integrate ZIVO's algal biomass ingredient into food processing lines and products, and to include its nutritional information on product labels.

The present GRAS review is based on commercial-scale cultivation processes and parameters, which better represent ZIVO's planned commercial product. The analysis concludes that ZIVO's algal biomass, as cultivated for commercial use, is exempt from the premarket approval requirements of the FDA.